Omacetaxine Mepesuccinate Injection
Sponsors
The University of Hong Kong
Conditions
AMLFLT3-ITD Mutation
Phase 2
Combination of Quizartinib and Omacetaxine Mepesuccinate for AML Carrying FLT3-ITD
NCT03135054
Start: 2017-10-01End: 2021-10-01Target: 40Updated: 2020-12-10
Combination of Sorafenib and Omacetaxine Mepesuccinate in Newly Diagnosed or Relapsed/Refractory AML Carrying FLT3-ITD
CompletedNCT03170895
Start: 2017-07-01End: 2020-03-01Updated: 2020-03-30